Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 78

1.

Understanding and perceptions of final-year Doctor of Pharmacy students about generic medicines in Karachi, Pakistan: a quantitative insight.

Jamshed SQ, Ibrahim MI, Hassali MA, Sharrad AK, Shafie AA, Babar ZU.

Adv Med Educ Pract. 2015 May 15;6:359-66. doi: 10.2147/AMEP.S27762. eCollection 2015.

2.

Duration of treatment in pulmonary tuberculosis: are international guidelines on the management of tuberculosis missing something?

Atif M, Sulaiman SA, Shafie AA, Babar ZU.

Public Health. 2015 Jun;129(6):777-82. doi: 10.1016/j.puhe.2015.04.010. Epub 2015 May 18.

PMID:
25999175
3.

Assessment of knowledge, attitude and practice of food allergies among food handlers in the state of Penang, Malaysia.

Shafie AA, Azman AW.

Public Health. 2015 Apr 27. pii: S0033-3506(15)00133-X. doi: 10.1016/j.puhe.2015.03.016. [Epub ahead of print]

PMID:
25931434
4.

Economic evaluation of enhanced asthma management: a systematic review.

Yong YV, Shafie AA.

Pharm Pract (Granada). 2014 Oct;12(4):493. Epub 2014 Mar 15.

5.

An analysis of the cost-effectiveness of switching from biphasic human insulin 30, insulin glargine, or neutral protamine Hagedorn to biphasic insulin aspart 30 in people with type 2 diabetes.

Gupta V, Baabbad R, Hammerby E, Nikolajsen A, Shafie AA.

J Med Econ. 2015 Apr;18(4):263-72. doi: 10.3111/13696998.2014.991791. Epub 2015 Jan 2.

PMID:
25426701
6.

Exploring the willingness to pay for a quality-adjusted life-year in the state of Penang, Malaysia.

Shafie AA, Lim YW, Chua GN, Hassali MA.

Clinicoecon Outcomes Res. 2014 Oct 23;6:473-81. doi: 10.2147/CEOR.S67375. eCollection 2014.

7.

An analysis of the short- and long-term cost-effectiveness of starting biphasic insulin aspart 30 in insulin-naïve people with poorly controlled type 2 diabetes.

Shafie AA, Gupta V, Baabbad R, Hammerby E, Home P.

Diabetes Res Clin Pract. 2014 Nov;106(2):319-27. doi: 10.1016/j.diabres.2014.08.024. Epub 2014 Sep 16.

8.

Study protocol of EMPOWER participatory action research (EMPOWER-PAR): a pragmatic cluster randomised controlled trial of multifaceted chronic disease management strategies to improve diabetes and hypertension outcomes in primary care.

Ramli AS, Lakshmanan S, Haniff J, Selvarajah S, Tong SF, Bujang MA, Abdul-Razak S, Shafie AA, Lee VK, Abdul-Rahman TH, Daud MH, Ng KK, Ariffin F, Abdul-Hamid H, Mazapuspavina MY, Mat-Nasir N, Miskan M, Stanley-Ponniah JP, Ismail M, Chan CW, Abdul-Rahman YR, Chew BH, Low WH.

BMC Fam Pract. 2014 Sep 13;15:151. doi: 10.1186/1471-2296-15-151.

9.

Resource utilization pattern and cost of tuberculosis treatment from the provider and patient perspectives in the state of Penang, Malaysia.

Atif M, Sulaiman SA, Shafie AA, Asif M, Babar ZU.

BMC Health Serv Res. 2014 Aug 19;14:353. doi: 10.1186/1472-6963-14-353.

10.

Job satisfaction, organisation commitment and retention in the public workforce: a survey among pharmacists in Malaysia.

Chua GN, Yee LJ, Sim BA, Tan KH, Sin NK, Hassali MA, Shafie AA, Ooi GS.

Int J Pharm Pract. 2014 Aug;22(4):265-74.

PMID:
25121161
11.

Treatment outcome of new smear positive pulmonary tuberculosis patients in Penang, Malaysia.

Atif M, Sulaiman SA, Shafie AA, Ali I, Asif M, Babar ZU.

BMC Infect Dis. 2014 Jul 19;14:399. doi: 10.1186/1471-2334-14-399.

12.
13.

Systematic review of factors affecting pharmaceutical expenditures.

Mousnad MA, Shafie AA, Ibrahim MI.

Health Policy. 2014 Jun;116(2-3):137-46. doi: 10.1016/j.healthpol.2014.03.010. Epub 2014 Mar 27.

PMID:
24726509
14.

Impact of tuberculosis treatment on health-related quality of life of pulmonary tuberculosis patients: a follow-up study.

Atif M, Sulaiman SA, Shafie AA, Asif M, Sarfraz MK, Low HC, Babar ZU.

Health Qual Life Outcomes. 2014 Feb 14;12:19. doi: 10.1186/1477-7525-12-19.

15.

The use of potentially inappropriate medications and changes in quality of life among older nursing home residents.

Al Aqqad SM, Chen LL, Shafie AA, Hassali MA, Tangiisuran B.

Clin Interv Aging. 2014 Jan 22;9:201-7. doi: 10.2147/CIA.S52356. eCollection 2014.

16.

Tuberculosis deaths: are we measuring accurately?

Atif M, Sulaiman SA, Shafie AA, Qamar Uz Zaman M, Asif M.

J Pharm Policy Pract. 2014 Nov 14;7(1):16. doi: 10.1186/2052-3211-7-16. eCollection 2014.

17.

Why hospital pharmacists have failed to manage antimalarial drugs stock-outs in pakistan? A qualitative insight.

Malik M, Hassali MA, Shafie AA, Hussain A.

Malar Res Treat. 2013;2013:342843. doi: 10.1155/2013/342843. Epub 2013 Oct 7.

18.

Case management of malaria fever at community pharmacies in Pakistan: a threat to rational drug use.

Malik M, Hassali MA, Shafie AA, Hussain A, Aljadhey H, Saleem F.

Pharm Pract (Granada). 2013 Jan;11(1):8-16. Epub 2013 Mar 28.

19.

Standard treatment guidelines for malaria: Challenges in its implementation in Islamabad (federal capital) and Rawalpindi (twin city), Pakistan.

Malik M, Hussain A, Hassali MA, Shafie AA.

Saudi Pharm J. 2013 Jan;21(1):123-4. doi: 10.1016/j.jsps.2012.02.005. No abstract available.

20.

Cross Sectional Assessment of Health Related Quality of Life (HRQoL) among patients with cancer in Malaysia.

Farooqui M, Hassali MA, Knight A, Shafie AA, Farooqui MA, Saleem F, ul Haq N, Othman CN, Aljadhey H.

Asian Pac J Cancer Prev. 2013;14(5):3017-21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk